On the appropriateness of antibody selection to estimate mTORC1 activity

Acta Physiol (Oxf). 2020 Feb;228(2):e13354. doi: 10.1111/apha.13354. Epub 2019 Aug 13.

Authors

Vandre C Figueiredo^{1

2}, Cory M Dungan^{1

2}, Charlotte A Peterson^{1

2}, John J McCarthy^{2

3}

Affiliations

¹ Department of Rehabilitation Sciences, College of Health Sciences, University of Kentucky, Lexington, Kentucky.
² The Center for Muscle Biology, University of Kentucky, Lexington, Kentucky.
³ Department of Physiology, College of Medicine, University of Kentucky, Lexington, Kentucky.

PMID: 31365789
DOI: 10.1111/apha.13354

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies*
Mechanistic Target of Rapamycin Complex 1
Muscle, Skeletal
Signal Transduction
TOR Serine-Threonine Kinases*

Substances

Antibodies
Mechanistic Target of Rapamycin Complex 1
TOR Serine-Threonine Kinases